Association of RDW-Albumin Ratio, TG-Glucose Index, and PIV with Coronary Artery Disease

Emre Akkaya1

  • 1Department of Cardiology, Bossan Hospital, Gaziantep 27580, Turkey.

PubMed

Insights

New biomarkers like the RDW-albumin ratio (RAR), Triglyceride-glucose index (TGI), and pan-immune-inflammation value (PIV) show promise for predicting coronary artery disease (CAD) risk. Their combined use offers improved diagnostic accuracy for CAD detection.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Predictive Medicine

Background:

  • Coronary artery disease (CAD) poses a significant global health challenge.
  • Accurate prediction and early diagnosis of CAD are crucial for effective management and improved patient outcomes.
  • Novel biomarkers are needed to enhance the diagnostic accuracy beyond traditional risk factors.

Purpose of the Study:

  • To investigate the prognostic value of the RDW-albumin ratio (RAR), Triglyceride-glucose index (TGI), and pan-immune-inflammation value (PIV) in patients with CAD.
  • To assess the potential of these biomarkers for clinical decision-making in CAD diagnosis.
  • To evaluate the combined diagnostic accuracy of RAR, TGI, and PIV for CAD.

Main Methods:

  • Retrospective study of 450 CAD patients and 150 controls (2020-2024).
  • Analysis of RDW-albumin ratio (RAR), Triglyceride-glucose index (TGI), and pan-immune-inflammation value (PIV).
  • Statistical analysis including odds ratios (OR), confidence intervals (CI), and area under the curve (AUC).

Main Results:

  • RAR, TGI, and PIV were significantly elevated in the CAD group (p < 0.01).
  • High RAR (OR=1.4), TGI (OR=1.5), and PIV (OR=2.0) were identified as independent risk factors for CAD (p < 0.01).
  • Combined analysis of RAR, TGI, and PIV achieved an AUC of 0.78 (95% CI: 0.75-0.81) with 74% sensitivity and 77% specificity (p < 0.01).

Conclusions:

  • The RDW-albumin ratio, Triglyceride-glucose index, and pan-immune-inflammation value are significant predictors of CAD.
  • These novel biomarkers, when used in combination, demonstrate high diagnostic accuracy for CAD.
  • Integrating these biomarkers into clinical practice may enhance the prediction and management of coronary artery disease risk.